Adam R. Craig - 23 Oct 2025 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Key filing fact

Adam R. Craig filed Form 4 for X4 Pharmaceuticals, Inc (XFOR) on 27 Oct 2025.

Key facts

This page summarizes Adam R. Craig's Form 4 filing for X4 Pharmaceuticals, Inc (XFOR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Oct 2025, 18:40.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001339498 Primary reporting owner

Relationship: Executive Chairman, Director
Address: C/O X4 PHARMACEUTICALS INC., 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON
Signature: /s/ David Kirske, Attorney-In-Fact
Signature date: 27 Oct 2025

Shares, units, or other non-derivative securities reported in this filing.

XFOR transaction

Purchase

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Consists of shares of the Issuer's common stock purchased in connection with the Issuer's public offering.